Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Amazon
AMZN
|
+$228M |
| 3 |
Analog Devices
ADI
|
+$121M |
| 4 |
United Therapeutics
UTHR
|
+$105M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$238M |
| 2 |
DXC Technology
DXC
|
+$235M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 4 |
NXP Semiconductors
NXPI
|
+$158M |
| 5 |
Baidu
BIDU
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Healthcare | 20.55% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 7.32% |
| 5 | Communication Services | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Alphatec Holdings
ATEC
$1.43B
| $4.49M | 0.02% |
292,942
-344,358
| -54% | -$5.31M |
|
627
Inogen
INGN
$146M
| $4.46M | 0.02% |
68,400
+19,800
| +41% | +$1.25M |
|
628
Blink Charging
BLNK
$84.7M
| $4.45M | 0.02% |
108,100
+58,290
| +117% | +$2.16M |
|
629
Shift4
FOUR
$3.79B
| $4.43M | 0.02% |
47,300
+40,500
| +596% | +$3.82M |
|
630
Hartford Financial Services
HIG
$37.6B
| $4.34M | 0.02% |
70,000
-43,500
| -38% | -$2.85M |
|
631
Avalo Therapeutics
AVTX
$1.03B
| $4.27M | 0.02% |
453
-398
| -47% | -$3.33M |
|
|
AZEK
632
DELISTED
The AZEK Co
AZEK
| $4.25M | 0.02% |
+100,000
| New | +$4.48M |
|
|
ACOR
633
DELISTED
Acorda Therapeutics
ACOR
| $4.24M | 0.02% |
44,445
-136
| -0.3% | -$11.9K |
|
634
Porch Group
PRCH
$1.94B
| $4.2M | 0.02% |
+216,993
| New | +$3.58M |
|
635
Constellation Brands
STZ
$23.5B
| $4.15M | 0.02% |
+17,735
| New | +$4.16M |
|
636
CALL
Hershey
HSY
$38.2B
| $4.14M | 0.02% |
+23,800
| New | +$4.01M |
|
637
Portland General Electric
POR
$5.85B
| $4.13M | 0.02% |
89,700
-108,636
| -55% | -$5.34M |
|
638
Cheesecake Factory
CAKE
$5.7B
| $4.13M | 0.02% |
+76,188
| New | +$4.41M |
|
639
Lightspeed Commerce
LSPD
$1.37B
| $4.09M | 0.02% |
+48,900
| New | +$3.44M |
|
640
Viavi Solutions
VIAV
$9.12B
| $4.09M | 0.02% |
+231,400
| New | +$3.9M |
|
|
CCC
641
CCC Intelligent Solutions
CCC
$4.42B
| $4.08M | 0.02% |
409,534
+359,534
| +719% | +$3.63M |
|
|
CAN
642
CALL
Canaan Creative
CAN
$268M
| $4.08M | 0.02% |
+500,000
| New | +$5.68M |
|
|
CUTR
643
DELISTED
Cutera, Inc.
CUTR
| $4.07M | 0.02% |
+83,056
| New | +$3.05M |
|
644
Matador Resources
MTDR
$7.12B
| $4.05M | 0.02% |
+112,365
| New | +$3.28M |
|
645
Wells Fargo
WFC
$256B
| $4.03M | 0.02% |
88,900
+58,100
| +189% | +$2.59M |
|
646
Madison Square Garden
MSGS
$9.69B
| $4.01M | 0.02% |
23,257
-4,841
| -17% | -$875K |
|
647
Terex
TEX
$7.53B
| $4.01M | 0.02% |
84,129
+2,743
| +3% | +$133K |
|
648
Itron
ITRI
$4.32B
| $3.99M | 0.02% |
39,900
-52,600
| -57% | -$4.88M |
|
649
Kosmos Energy
KOS
$1.7B
| $3.98M | 0.02% |
+1,149,300
| New | +$3.56M |
|
|
MRSH
650
Marsh
MRSH
$92.9B
| $3.91M | 0.02% |
+27,800
| New | +$3.73M |
|
Similar funds
Steven Cohen's Q2 2021 Portfolio in Review
As of Q2 2021, Steven Cohen held 1,274 positions worth $22.3B, up 4% from $21.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Steven Cohen's Q2 2021 filing shows 347 new, 260 increased, 248 reduced and 334 closed positions. Its largest new stake was United Therapeutics: 552,400 shares worth $99.1M. The largest sale was Applied Materials, an estimated $238M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Steven Cohen's largest Q2 2021 buy was United Therapeutics: 552,400 shares worth $99.1M.
- Steven Cohen added most to Salesforce in Q2 2021, an estimated $372M increase.
- Steven Cohen's biggest Q2 2021 reduction was Applied Materials, cutting an estimated $238M.
- Steven Cohen fully exited DXC Technology in Q2 2021, selling an estimated $235M.
- Steven Cohen's ten largest holdings make up 18% of its $22.3B portfolio in Q2 2021.
- Steven Cohen opened 347 new positions and closed 334 in Q2 2021.
- Steven Cohen's portfolio value rose 4% quarter-over-quarter to $22.3B.
Based on Point72 Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.